Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Sanara MedTech (SMTI) Shares Issued (2010 - 2023)

Sanara MedTech posted quarterly Shares Issued of -$122390.0 for Q4 2023, down 143.4% on a QoQ basis from $282009.0 in Q2 2023.

Sanara MedTech (SMTI) has 9 years of Shares Issued data on file, last reported at -$122390.0 in Q4 2023.

For the quarter ending Q4 2023, Shares Issued changed N/A year-over-year to -$122390.0; the trailing twelve-month figure through Dec 2024 stood at $159619.0 (down 82.49% YoY), and the FY2024 full-year result was -$75000.0, down 108.23% from the prior year.
Shares Issued for Q4 2023 stood at -$122390.0, down from $282009.0 in the prior quarter.
Across five years, Shares Issued topped out at $28.9 million in Q1 2021 and bottomed at -$122390.0 in Q4 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Intuitive Surgical	156.17 Bn	151.78 Bn	1.83 Bn	121.80 Mn
2	Becton Dickinson	41.51 Bn	40.49 Bn	2.15 Bn	-
3	Resmed	30.43 Bn	28.77 Bn	890.98 Mn	7.43 Mn
4	West Pharmaceutical Services	22.78 Bn	22.26 Bn	296.40 Mn	5.50 Mn
5	Solventum	13.39 Bn	13.39 Bn	1.10 Bn	-
6	Cooper Companies	12.33 Bn	12.20 Bn	695.20 Mn	3.90 Mn
7	Align Technology	11.65 Bn	10.59 Bn	736.59 Mn	11.72 Mn
8	Baxter International	9.81 Bn	7.77 Bn	891.00 Mn	8.00 Mn
9	Aptargroup	7.39 Bn	7.19 Bn	351.91 Mn	18.52 Mn
10	Sanara MedTech	203.69 Mn	190.09 Mn	25.87 Mn	-

Historic Data

Download Data 🔒

Date	Value
Dec 31, 2023	-122,390.00
Dec 31, 2023	-122,390.00
Jun 30, 2023	282,009.00
Jun 30, 2023	282,009.00
Mar 31, 2023	751,752.00
Mar 31, 2023	751,752.00
Mar 31, 2021	28.94 Mn
Mar 31, 2021	28.94 Mn
Mar 31, 2017	50,050.00
Mar 31, 2017	50,050.00
Jun 30, 2016	150,000.00
Jun 30, 2016	150,000.00
Mar 31, 2016	300,000.00
Mar 31, 2016	300,000.00
Sep 30, 2015	250,000.00
Sep 30, 2015	250,000.00
Jun 30, 2015	250,000.00
Jun 30, 2015	250,000.00
Mar 31, 2013	500,000.00
Mar 31, 2013	500,000.00
Dec 31, 2012	15,248.00
Dec 31, 2012	15,248.00
Dec 31, 2011	5,001.00
Dec 31, 2011	5,001.00
Sep 30, 2011	9,999.00
Sep 30, 2011	9,999.00
Jun 30, 2011	76,000.00
Jun 30, 2011	76,000.00
Mar 31, 2011	868,700.00
Mar 31, 2011	868,700.00
Dec 31, 2010	188,902.00
Dec 31, 2010	188,902.00